Akèy › Kansè vejik › Oregon › Eugene
Etid klinik pou Kansè vejik nan Eugene, OR
3 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
- Williamette Valley Cancer Institute and Research Center, Eugene
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Ap rekriteFaz 1/2
- Oncology Associates of Oregon, P.C., Eugene
- Oncology Associates of Oregon, P.C., Springfield · 3 mi lwen
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Ap rekriteFaz 2
- Oregon Urology Institute, Springfield · 3 mi lwen
Etid Kansè vejik nan lòt vil
- New York City, NY34 etid
- Nashville, TN31 etid
- Houston, TX31 etid
- Dallas, TX27 etid
- Washington, DC26 etid
- Boston, MA26 etid
- Los Angeles, CA24 etid
- Baltimore, MD24 etid
- St. Louis, MO22 etid
- Edison, NJ22 etid
- Philadelphia, PA21 etid
- Chicago, IL21 etid
Lòt etid nan Eugene
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè9 etid
- Kansè Endomèt8 etid
- Lukemi lenfositè kwonik7 etid
- Kansè nan tete7 etid
- Kansè Metastatik6 etid
- Kansè (tout kalite)6 etid
- Myelom Miltip6 etid
- Kansè poumon5 etid
- Degeneresans makile5 etid
- Itilizasyon Dwòg ak Depandans5 etid
- Obèsite4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.